Regionally advanced nasopharyngeal carcinoma: Long-term outcome after sequential chemotherapy and radiotherapy

Tumori

Volumn 90, Issue 1, 2004, Pages 60-65

  Palazzi, Mauro ^a   Guzzo, Marco ^a   Bossi, Paolo ^a   Tomatis, Stefano ^a   Cerrotta, Annamaria ^a   Cantú, Giulio ^a   Locati, Laura D ^a   Licitra, Lisa ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Chemotherapy; Late effects; Nasopharyngeal carcinoma; Patterns of failure; Radiotherapy

Indexed keywords

CISPLATIN; EPIRUBICIN;

ADVANCED CANCER; ANEMIA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CHEMOTHERAPY INDUCED EMESIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ELECTROCORTICOGRAPHY; FEMALE; FOLLOW UP; HEARING LOSS; HUMAN; KIDNEY DISEASE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; METASTASIS; MUCOSA INFLAMMATION; NASOPHARYNX CARCINOMA; NAUSEA; NEUTROPENIA; PHASE 2 CLINICAL TRIAL; RADIATION DOSE; SALVAGE THERAPY; SIDE EFFECT; THROMBOCYTOPENIA; TOOTH INJURY; TREATMENT OUTCOME; TRISMUS; XEROSTOMIA;

EID: 2142653014     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089160409000114     Document Type: Article

References (33)

1. Rossi A, Molinari R, Boracchi P, Del Vecchio M, Marubini E, Nava M, Morandi L, Zucali R, Pilotti S, Grandi C, Ambrosini G, Cellini L, Chiavacci A, Colombo A, Dal Fior S, De Maria M, Felci U, Gabriele P, Laddaga M, Magno L, Marziano C, Olmi P, Prino A, Roncoroni L, Torretta A, Zampi G, Zorat PL, De Palo G: Adjuvant chemotherapy with vincristine, cyclophosphamide, and doxorubicin after radiotherapy in local-regional nasopharyngeal cancer: results of a 4-year multicenter randomized study. J Clin Oncol, 6: 1401-1410, 1988.
2. Chan ATC, Teo PML, Leung TWT, Leung SF, Lee WY, Yeo W, Choi PHK, Johnson PJ: A prospective randomized study of chemotherapy adjunctive to definitive radiotherapy in advanced nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys, 33: 569-577, 1995.
3. International Nasopharynx Cancer Study Group: VUMCA I Trial: Preliminary results of a randomized trial comparing neoadjuvant chemotherapy (cisplatin, epirubicin, bleomycin) plus radiotherapy vs radiotherapy alone in stage IV (≥ N2, MO) undifferentiated nasopharyngeal carcinoma: a positive effect on progression-free survival. Int J Radiat Oncol Biol Phys, 35: 463-469, 1996.
4. Al-Sarraf M, LeBlanc M, Giri PGS, Fu KK, Cooper J, Vuong T, Forastiere AA, Adams G, Sakr WA, Schuller DE, Ensley JF: Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099. J Clin Oncol, 16: 1310-1317, 1998.
5. Chua DTT, Sham JST, Choy D, Lorvidhaya V, Sumitsawan Y, Thongprasert S, Vootiprux V, Cheirsilpa A, Azhar T, Reksodiputro AH: Preliminary report of the Asian-Oceanian Clinical Oncology Association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma. Cancer, 83: 2270-2283, 1998.
6. Ma J, Mai HQ, Hong MH, Min HQ, Mao ZD, Cui NJ, Lu TX, Mo HY: Results of a prospective randomized trial comparing neoadjuvant chemotherapy plus radiotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma. J Clin Oncol, 19: 1350-1357, 2001.
7. Chan ATC, Teo PML, Ngan RK, Leung TW, Lau WH, Zee B, Leung SF, Cheung FY, Yeo W, Yiu HH, Yu KH, Chu KW, Chan DT, Mok T, Yuen KT, Mo F, Lai M, Kwan WH, Choi P, Johnson PJ: Concurrent chemotherapy-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: progression-free survival analysis of a phase III randomized trial. J Clin Oncol, 20: 2038-2044, 2002.
8. Chua DTT, Sham JST, Choy D, Kwong DLW, Au GKH, Kwong PWK, Yau C-C, Cheng ACK, Wan K-Y: Patterns of failure after induction chemotherapy and radiotherapy for locoregionally advanced nasopharyngeal carcinoma: the Queen Mary Hospital experience. Int J Radiat Oncol Biol Phys, 49: 1219-1228, 2001.
9. Hareyama M, Sakata K, Shirato H, Nishioka T, Nishio M, Suzuki K, Saitoh A, Oouchi A, Fukuda S, Himi T: A prospective, randomized trial comparing neoadjuvant chemotherapy with radiotherapy alone in patients with advanced nasopharyngeal cancer. Cancer, 94: 2217-2223, 2002.
10. Chi KH, Chang YC, Guo WY, Leung MJ, Shiau CY, Chen SY, Wang LW, Lai YL, Hsu MM, Lian SL, Chang CH, Liu TW, Chin YH, Yen SH, Perng CH, Chen KY: A phase III study of adjuvant chemotherapy in advanced nasopharyngeal carcinoma patients. Int J Radiat Oncol Biol Phys, 52: 1238-1244, 2002.
11. Lin JC, Jan JS, Hsu CY, Liang WM, Jiang RS, Wang WY: Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: positive effect on overall and progression-free survival. J Clin Oncol, 21: 631-637, 2003.
12. th edn, Springer Verlag, Berlin, 1987.
13. Miller AB, Hoogstraten B, Staquet M, Winkler A: Reporting results of cancer treatment. Cancer, 47: 207-214, 1981.
14. Common Toxicity Criteria (CTC) version 2.0. CTEP Website. http://ctep.info.nih.gov
15. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc, 53: 457-481, 1958.
16. th edn, Wiley-Liss, New York, 1997.
17. Cox JD, Stetz J, Pajak TF: Toxicity criteria of the Radiation Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys, 31: 1341-1346, 1995.
18. LENT SOMA tables. Radiother Oncol, 35: 17-60, 1995.
19. Chua D, Sham J, Choy D: Control of regional metastasis after induction chemotherapy and radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys, 51 (Suppl 1): 43, 2001.
20. Hong S, Wu HG, Chie EK, Bang YJ, Heo DS, Kim KH, Sung MW, Park CI: Neoadjuvant chemotherapy and radiation therapy compared with radiation therapy alone in advanced nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys, 45: 901-905, 1999.
21. Geara FB, Glisson BS, Sanguineti G, Tucker SL, Garden AS, Ang KK, Lippman SM, Clayman GL, Goepfert H, Peters LJ, Hong WK: Induction chemotherapy followed by radiotherapy versus radiotherapy alone in patients with advanced nasopharyngeal carcinoma: results of a matched cohort study. Cancer, 79: 1279-1286, 1997.
22. Wolden SL, Zelefsky MJ, Kraus DH, Rosenzweig KE, Chong LM, Shaha AR, Zhang H, Harrison LB, Shah JP, Pfister DG: Accelerated concomitant boost radiotherapy and chemotherapy for advanced nasopharyngeal carcinoma. J Clin Oncol, 19: 1105-1110, 2001.
23. Kalogera-Fountzila A, Kosmidis P, Bacoyiannis C, Nicolau A, Samantas E, Briassoulis E, Pavlidis N, Skarlos D, Daniilidis J, Fountzilas G: Prognostic factors influencing complete response to treatment and survival of patients with nasopharyngeal cancer. Anticancer Res, 18: 587-594, 1998.
24. Kajanti M, Flander M, Grenman R, Hietanen T, Romppanen M, Turunen M, Valavaara R, Joensuu H: Treatment results of nasopharyngeal cancer. A nationwide survey from Finland. Acta Oncol, 35: 697-702, 1996.
25. Levendag PC, Schmitz PI, Jansen PP, Eijkenboom WM, Visser AG, Kolkman-Deurloo IK, Sipkema D, Visch LL, Senan S: Fractionated high-dose rate brachytherapy in primary carcinoma of the nasopharynx. J Clin Oncol, 16: 2213-2220, 1998.
26. Sanguineti G, Geara FB, Garden AS, Tucker SL, Ang KK, Morrison WH, Peters LJ: Carcinoma of the nasopharynx treated by radiotherapy alone: determinants of local and regional control. Int J Radiat Oncol Biol Phys, 37: 985-996, 1997.
27. Chua DT, Sham JS, Kwong DL, Tai KS, Wu PM, Lo M, Yung A, Choi D, Leong L: Volumetric analysis of tumor extent in nasopharyngeal carcinoma and correlation with treatment outcome. Int J Radiat Oncol Biol Phys, 39: 711-719, 1997.
28. Santos JA, Gonzales Cuesta P, De la Fuente I: Impact of changes in the treatment of nasopharyngeal carcinoma: an experience of 30 years. Radiother Oncol, 36: 121-127, 1995.
29. Johansen LV, Grau C, Overgaard J: Squamous cell carcinoma of the nasopharynx - an analysis of treatment results in 149 consecutive patients. Acta Oncol, 40: 801-809, 2001.
30. Teo PML, Chan ATC: Treatment strategy and clinical experience. Semin Cancer Biol 12: 497-504, 2002.
31. Oh JL, Vokes EE, Kies MS, Mittal BB, Witt ME, Weichselbaum RR, Haraf DJ: Induction chemotherapy followed by concomitant chemoradiotherapy in the treatment of locoregionally advanced nasopharyngeal cancer. Ann Oncol, 14: 564-569, 2003.
32. Rischin D, Corry J, Smith J, Stewart J, Hughes P, Peters L: Excellent disease control and survival in patients with advanced nasopharyngeal cancer treated with chemoradiation. J Clin Oncol, 20: 1845-1852, 2002.
33. Teo P, Yu P, Lee WY, Leung SF, Kwan WH, Yu KH, Choi P, Johnson PJ: Significant prognosticators after primary radiotherapy in 903 nondisseminated nasopharyngeal carcinoma evaluated by computed tomography. Int J Radiat Oncol Biol Phys, 36: 291-304, 1996.